Human tuberculosis caused by Mycobacterium bovis in the United States, Latin America and the Caribbean

International Journal of Tuberculosis and Lung Disease

Volumn 14, Issue 11, 2010, Pages 1369-1373

  De Kantor, I N ^a   LoBue, P A ^b   Thoen, Charles O ^c  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c IOWA STATE UNIVERSITY   (United States)

Author keywords

Humans; M. Bovis; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ANTIBIOTIC THERAPY; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CENTRAL AMERICA; DIRECTLY OBSERVED THERAPY; DISEASE TRANSMISSION; DRUG EFFICACY; GENOTYPE; HUMAN; INCIDENCE; MICROSCOPY; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SOUTH AND CENTRAL AMERICA; SPUTUM SMEAR; TUBERCULOSIS; UNITED STATES;

ANIMALS; CARIBBEAN REGION; CATTLE; DAIRY PRODUCTS; HUMANS; INCIDENCE; LATIN AMERICA; MYCOBACTERIUM BOVIS; PREVALENCE; TUBERCULOSIS; TUBERCULOSIS, BOVINE; UNITED STATES;

EID: 78049429922     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. World Health Organization. Global TB control. A short update to the 2009 report. Geneva, Switzerland: WHO, 2009. http://www.who.int/tb/publications/ global-report/2009/update/tbu-9.pdf Accessed January 2010.
2. World Health Organization. Tuberculosis world report 2008. Estimated burden of TB, the Americas. Geneva, Switzerland: WHO, 2008. http://www.who.int/ tb/publications/global-report/2008/pdf/annex3-amr.pdf Accessed February 2009.
3. Chavadi S, Wooff E, Coldham N G, et al. Global effects of inactivation of the pyruvate kinase gene in the Mycobacterium tuberculosis complex. J Bacteriol 2009; 191: 7545-7553.
4. Keating L A, Wheeler P R, Mansoor H, et al. The pyruvate requirement of some members of the Mycobacterium tuberculosis complex is due to an inactive pyruvate kinase: implications for in vivo growth. Mol Microbiol 2005; 56: 163-174.
5. de Kantor I N, Ambroggi M, Poggi S, et al. Human Mycobacterium bovis infection in ten Latin American countries. Tuberculosis (Edinb) 2008; 88: 358-365.
6. Pan-American Health Organization/World Health Organization. Manual para el diagnóstico bacteriológico de la tuberculosis. Normas y Guía Técnica. Parte II: Cultivo, 2008. Washington DC, USA: PAHO, 2008. http://www.paho.org/Spanish/HCP/HCT/TUB/tuberculosis.htm Accessed April 2009. [Spanish]
7. Hlavsa M, Moonan P M, Cowan L S, et al. Human tuberculosis caused by Mycobacterium bovis - United States, 1995-2005. Clin Infect Dis 2008; 47: 168-175.
8. World Health Organization. Guidelines for surveillance of drug resistance in tuberculosis. 4th ed. WHO/HTM/TB/2009. 422. Geneva, Switzerland: WHO, 2009. http://whqlibdoc.who.int/publications/2009/9789241598675-eng.pdf Accessed January 2010.
9. LoBue P A, Betacourt W, Peter C, Moser K S. Epidemiology of Mycobacterium bovis disease in San Diego County, 1994-2000. Int J Tuberc Lung Dis 2003; 7: 180-185.
10. Centers for Disease Control and Prevention. Human tuberculosis caused by Mycobacterium bovis - New York City, 2001-2004. MMWR Morb Mortal Wkly Rep 2005; 54: 605-608.
11. Besser R E, Pakiz B, Schulte J M, et al. Risk factors for positive Mantoux tuberculin skin tests in children in San Diego, California: evidence for boosting and possible foodborne transmission. Pediatrics 2001; 108: 305-310.
12. Blazquez J, de Los Monteros L E E, Samper S, et al. Genetic characterization of multidrug-resistant Mycobacterium bovis strains from a hospital outbreak involving human immunodeficiency virus-positive patients. J Clin Microbiol 1997; 35: 1390-1393.
13. Evans J T, Sonnenberg P, Smith E G, et al. Bovine tuberculosis: multiple human-to-human transmission in the UK. Lancet 2007; 14: 1270-1276.
14. Sunder S, Lanotte P, Godreuil S, Martin C, Boschiroli M L, Besnier J M. Human-to-human transmission of tuberculosis caused by Mycobacterium bovis in immunocompetent patients. J Clin Microbiol 2009; 47: 1249-1251.
15. Etchechoury I, Valencia G E, Morcillo N, et al. Molecular typing of Mycobacterium bovis isolates in Argentina: first description of a person to person transmission case. Zoonoses Public Health 2009; Nov 13 [Epub ahead of print].
16. LoBue P A, Moser K S. Treatment of Mycobacterium bovis infected tuberculosis patients, San Diego, California, United States, 1994-2003. Int J Tuberc Lung Dis 2005; 9: 333-338.
17. Fanning A, Edwards S. Mycobacterium bovis infection in human beings in contact with elk (Cervus elaphus) in Alberta, Canada. Lancet 1991; 338: 1253-1255.
18. de Kantor I N, Ritacco V. An update on bovine tuberculosis programmes in Latin American and Caribbean countries. Vet Microbiol 2006; 112: 111-118. (Pubitemid 43182743)
19. Ritacco V, Sequeira M D, de Kantor I N. Human tuberculosis caused by Mycobacterium bovis in Latin America and the Carribbean. In: Thoen C O, Steele J H, Gilsdorf M J, eds. Mycobacterium bovis infection in animals and humans. 2nd ed. Ames, IA, USA: Blackwell, 2006: pp 13-17.
20. Pérez-Guerrero L, Milián-Suazo F, Arriaga-Díaz Q C, Romero-Torres C, Escartín-Chávez M. Molecular epidemiology of cattle and human tuberculosis in Mexico. Salud Pública Méx 2008; 50: 286-291.
21. Milián-Suazo F, Salman M D, Ramirez C, Payeur J B, Rhyan J C, Santillan M. Identification of tuberculosis in cattle slaughtered in Mexico. Am J Vet Res 2000; 61: 86-89.
22. Zendejas Martínez H, Milián-Suazo F, Cuador Gil Q, et al. Spatial epidemiology of bovine tuberculosis in Mexico. Vet Ital 2007; 43: 629-634.